PYMNTS.com:
RapidAI, which develops AI-powered software to help diagnose neurovascular, cardiac, and vascular diseases, raised a $75M Series C led by Vista Credit Partners — RapidAI has secured $75 million in Series C funding to continue developing its clinical artificial intelligence (AI) solutions.